Evolution of breast cancer management: focus on neoadjuvant chemotherapy.
Heys
S D
SD
Section of Surgical Oncology, Department of Surgery, and the Aberdeen Breast Unit, University Medical Buildings, University of Aberdeen, Foresterhill, Aberdeen AB9 2ZD, Scotland, UK. s.d.heys@abdn.ac.uk
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D005260:Female; D005544:Forecasting; D006801:Humans; D020360:Neoadjuvant Therapy / Q000592:standards / Q000639:trends*; D011379:Prognosis; D011878:Radiotherapy / Q000592:standards / Q000639:trends*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D016896:Treatment Outcome